Identifying and Advancing Underdeveloped Candidates
By leveraging our deep understanding of tumor biology and translational drug development expertise, we seek to identify and acquire select underdeveloped drug candidates, and specifically target them to patients whose tumors are most likely to respond to therapy.
View Our Approach